Skip to main content

October 2019 Seminars with Pain Specialists

September Banner.jpgThe seminars will examine the specific conditions for which LDN has been shown to be an effective, non-opioid, treatment option for patients experiencing moderate to severe pain, including Complex Regional Pain Syndrome (CRPS), Fibromyalgia, Neuropathies, back pain, and autoimmune disease. In addition, LDN’s unique ability to control pain in opioid-dependent patients, and assist in the tapering and elimination of opioids, will be reviewed. A comprehensive review of the current literature will be discussed, it’s mechanism of action, as well as the clinical experience gained from the treatment of thousands of LDN patients, to form the clinical indication specific dosing guidance and titration protocols which are essential to achieving therapeutic success for patients.